{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-286248","form_type":"8-K","ticker":"DCTH","cik":"0000872912","company_name":"DELCATH SYSTEMS, INC.","filed_at":"2024-12-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.187476+00:00","generated_at":"2026-05-28T22:57:56.806347+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Delcath Systems receives $16.3M from Series E and E1 warrant exercises","bullets":["1,746,424 warrants exercised; 1,045,157 shares of common stock and 603,954 pre-funded warrants issued.","Gross proceeds of approximately $16.3 million; ~6.6% of exercises were cashless.","Warrants had $10.00 exercise price, issued in July/August 2019, expired Dec 24, 2024.","CEO states cash position strong to fund HEPZATO commercialization and clinical trials.","Warrant amendments allow pre-funded warrants to avoid exceeding 9.99% beneficial ownership cap."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-286248","json":"https://secwatch.observer/filing/0001193125-24-286248.json","markdown":"https://secwatch.observer/filing/0001193125-24-286248.md","text":"https://secwatch.observer/filing/0001193125-24-286248.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/872912/000119312524286248/0001193125-24-286248-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/872912/000119312524286248/d924758d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T22:57:56.806347+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}